Pfenex Inc. (PFNX): Price and Financial Metrics


Pfenex Inc. (PFNX)

Today's Latest Price: $7.51 USD

0.05 (0.67%)

Updated Jun 3 11:48am

Add PFNX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

PFNX Stock Summary

  • PFNX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 10.89% of US stocks.
  • With a year-over-year growth in debt of 685.75%, Pfenex Inc's debt growth rate surpasses 97.19% of about US stocks.
  • As for revenue growth, note that PFNX's revenue has grown 89.29% over the past 12 months; that beats the revenue growth of 93.78% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Pfenex Inc are CDXS, AWRE, PTCT, ATNX, and AKCA.
  • Visit PFNX's SEC page to see the company's official filings. To visit the company's web site, go to www.pfenex.com.
PFNX Daily Price Range
PFNX 52-Week Price Range

PFNX Stock Price Chart More Charts


PFNX Price/Volume Stats

Current price $7.51 52-week high $14.00
Prev. close $7.46 52-week low $5.26
Day low $7.23 Volume 51,736
Day high $7.63 Avg. volume 339,286
50-day MA $7.22 Dividend yield N/A
200-day MA $9.36 Market Cap 256.99M

Pfenex Inc. (PFNX) Company Bio


Pfenex is a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics and high-value and difficult to manufacture proteins. Pfenex was founded in 2009 and was based in San Diego, California.


PFNX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

PFNX Latest Social Stream


Loading social stream, please wait...

View Full PFNX Social Stream

Latest PFNX News From Around the Web

Below are the latest news stories about Pfenex Inc that investors may wish to consider to help them evaluate PFNX as an investment opportunity.

Pfenex Inc. Shareholders Who Have Suffered Losses Greater Than $50K Encouraged To Contact Kehoe Law Firm, P.C.

PHILADELPHIA, May 27, 2020 -- Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of shareholders Pfenex Inc. (“Pfenex” or the “Company”) (NYSE: PFNX).

Yahoo | May 27, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfenex Inc. - PFNX

NEW YORK, May 27, 2020 -- Pomerantz LLP is investigating claims on behalf of investors of Pfenex Inc. (“Pfenex” or the “Company”) (NYSE: PFNX). Such investors are advised to.

Yahoo | May 27, 2020

Edited Transcript of PFNX earnings conference call or presentation 7-May-20 8:30pm GMT

Q1 2020 Pfenex Inc Earnings Call

Yahoo | May 26, 2020

Pfenex Inc. (NYSEMKT:PFNX) Analysts Are Reducing Their Forecasts For This Year

The latest analyst coverage could presage a bad day for Pfenex Inc. (NYSEMKT:PFNX), with the analysts making...

Yahoo | May 18, 2020

Pfenex Reports First Quarter 2020 Results and Provides Business Update

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its proprietary protein production platform, Pfenex Expression Technology®, to develop next generation and novel protein therapeutics to meaningfully improve existing therapies and create novel therapies for some of the biological targets linked to critical diseases still waiting to successfully be addressed. Pfenex has developed a pipeline that is diversified across multiple assets, including a U.S. Food and Drug Administration (FDA)-approved PF708 product indicated for the treatment of osteoporosis in certain patients at high risk for fracture, and novel and next generation therapeutic product candidates. “We believe this is an exciting time for Pfenex as we continue to work ...

Yahoo | May 7, 2020

Read More 'PFNX' Stories Here

PFNX Price Returns

1-mo 35.07%
3-mo -34.75%
6-mo -29.28%
1-year 5.77%
3-year 75.06%
5-year -62.20%
YTD -31.60%
2019 244.20%
2018 19.92%
2017 -70.67%
2016 -26.74%
2015 72.42%

Continue Researching PFNX

Here are a few links from around the web to help you further your research on Pfenex Inc's stock as an investment opportunity:

Pfenex Inc (PFNX) Stock Price | Nasdaq
Pfenex Inc (PFNX) Stock Quote, History and News - Yahoo Finance
Pfenex Inc (PFNX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8718 seconds.